Alnylam Pharmaceuticals shares owned by Bridgewater Associates
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Bridgewater Associates
from 13F filings
Historical chart of Bridgewater Associates investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Bridgewater Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Bridgewater Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $16M | 34k | 456.00 |
| 2024-12-31 | $1.5M | 6.5k | 235.31 |
| 2024-09-30 | $551k | 2.0k | 275.03 |
| 2023-12-31 | $373k | 2.0k | 191.41 |
| 2023-09-30 | $334k | 1.9k | 177.10 |
| 2023-06-30 | $341k | 1.8k | 189.94 |
| 2023-03-31 | $251k | 1.3k | 200.32 |
| 2022-09-30 | $257k | 1.3k | 200.31 |
| 2022-06-30 | $221k | 1.5k | 146.16 |
| 2021-09-30 | $422k | 2.2k | 188.90 |
| 2021-06-30 | $1.0M | 6.1k | 169.54 |